IMAC Holdings, Inc. Closes $17.0 Million Public Offering of Common Stock
Lucosky Brookman LLP (www.lucbro.com) is pleased to announce that IMAC Holdings, Inc. (the “Company” or “IMAC”) (NASDAQ: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, closed its underwritten registered public offering of 10,625,000 shares of its common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million
IMAC intends to use the net proceeds from the proposed offering to finance acquisitions of medical clinics, repay outstanding promissory notes, fund the launch of retail healthcare clinics, and further develop potential new treatments, and for working capital and general corporate purposes.
Lucosky Brookman LLP represented Kingswood Capital Markets who acted as sole bookrunning manager for the offering.